Megestin en es it fr

Megestin Brand names, Megestin Analogs

Megestin Brand Names Mixture

  • No information avaliable

Megestin Chemical_Formula

C7H7NO3

Megestin RX_link

http://www.rxlist.com/cgi/generic2/canasa.htm

Megestin fda sheet

Megestin FDA

Megestin msds (material safety sheet)

Megestin MSDS

Megestin Synthesis Reference

No information avaliable

Megestin Molecular Weight

153.135 g/mol

Megestin Melting Point

283 oC

Megestin H2O Solubility

0.84 g/L at 20°C

Megestin State

Solid

Megestin LogP

1.012

Megestin Dosage Forms

Rectal suppository (500 mg or 1000 mg)

Megestin Indication

For the treatment of active ulcerative proctitis.

Megestin Pharmacology

Sulfasalazine has been used in the treatment of ulcerative colitis for over 55 years. It is split by bacterial action in the colon into sulfapyridine (SP) and mesalamine (5-ASA). It is thought that the mesalamine component only is therapeutically active in ulcerative colitis.

Megestin Absorption

20 to 30% absorbed following oral administration. 10 to 35% absorbed from the colon (rectal suppository) - extent of absorption is determined by the length of time the drug is retained in the colon.

Megestin side effects and Toxicity

Oral, mouse: LD50 = 3370 mg/kg; Oral, rat: LD50 = 2800 mg/kg; Skin, rabbit: LD50 = >5 gm/kg. There have been no documented reports of serious toxicity in man resulting from massive overdosing with mesalamine. Under ordinary circumstances, mesalamine absorption from the colon is limited.

Megestin Patient Information

Megestin Organisms Affected

Humans and other mammals